Windlas Biotech Ltd Share Price

Overview

Windlas Biotech Ltd share price is currently ₹976.21, down by - ₹7.42 (0.75%) from its previous closing price of ₹983.63. The share price has gained 15.24% over the past month and gained 1% over the past year. The stock's 52-week low and high are ₹691.90 and ₹1,025.00, respectively. Windlas Biotech Ltd has a market capitalisation of ₹ 2,050.00 Cr. The share price was last updated on 24 Aug 2026, 03:55 PM IST.

Windlas Biotech Ltd

WINDLAS

₹0.00

- ₹7.42

0.75%

Healthcare

₹0.00(%)1D

Updated: 24 Aug 2026, 03:55:34 pm IST

Market Data

Open Price

₹985.59

Prev. Close

₹983.63

₹969.98

Day Low

₹988.65

Day High

₹691.90

52 Week Low

₹1,025.00

52 Week High

HealthcarePharmaceuticals & Drugs

CategorySmall Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

30.81

Sector PE

42.03

PB Ratio

3.67

Sector PB

5.82

EPS

31.68

Dividend Yield

0.85

Today's Volume

156.338 K

5 Day Avg. Volume

189.684 K

PEG Ratio

3.76

Market Cap.

₹ 2,050.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Actions	Ex-Date	Record-Date
DividendsFinal Dividend of 126% at ₹6.3/Share	16-Jul-2026	16-Jul-2026
DividendsFinal Dividend of 116% at ₹5.8/Share	21-Jul-2025	21-Jul-2025
DividendsFinal Dividend of 110% at ₹5.5/Share	17-Sep-2024	18-Sep-2024

Mutual Fund Ownership

Mutual Fund Holder	Jun 26 Shares held	Jul 26 Shares held
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth	5.98 Lac	5.98 Lac no change
Bandhan Small Cap Fund - Regular Plan - Growth	2.95 Lac	2.95 Lac no change
UTI Healthcare Fund - Regular Plan - IDCW	1.86 Lac	1.86 Lac no change
JM Small Cap Fund - Regular Plan - Growth	-	26.80 k (100%)
Motilal Oswal BSE Healthcare ETF	210	215 (2.38%)

Show all holdings

About Windlas Biotech Ltd 👋

Windlas Biotech Limited is a domestic pharmaceutical formulations contract development and manufacturing organization (CDMO). Its portfolio of CDMO solutions includes product development, licensing, and commercial manufacturing of complex drugs and dosage forms. Its product development and manufacturing capabilities in complex generic products by developing products, including alternate dosages, such as, medicated mouth sprays; coating technologies, including, pellet coating using bottom spray, API coating, pH dependent coating and nanosized crystals; nutraceuticals dosages, including, biscuits, protein powder, supplements, chocolate bars and malt based foods, and ayurvedic products, such as wellness products, hair oils and cough syrups. Its four fungible, Schedule-M compliant OSD/OLD manufacturing facilities are located in Dehradun, Uttarakhand, India. It specializes in manufacturing formulations, solid pharmaceutical dosage forms, liquid pharmaceutical dosage forms and injectables.